Asymptomatic peripheral arterial disease: is pharmacological prevention of cardiovascular risk cost-effective?

B Sigvant, F Lundin - European Journal of Preventive Cardiology, 2011 - academic.oup.com
Peripheral arterial disease (PAD) is associated with an increased risk of early death in
cardiovascular (CV) disease. The majority of PAD subjects are asymptomatic with a …

Asymptomatic peripheral arterial disease: is pharmacological prevention of cardiovascular risk cost-effective?

B Sigvant, M Henriksson, F Lundin… - European Journal of …, 2011 - europepmc.org
Peripheral arterial disease (PAD) is associated with an increased risk of early death in
cardiovascular (CV) disease. The majority of PAD subjects are asymptomatic with a …

Asymptomatic peripheral arterial disease: is pharmacological prevention of cardiovascular risk cost-effective?

B Sigvant, M Henriksson, F Lundin… - European Journal of …, 2011 - journals.sagepub.com
Peripheral arterial disease (PAD) is associated with an increased risk of early death in
cardiovascular (CV) disease. The majority of PAD subjects are asymptomatic with a …

Asymptomatic peripheral arterial disease: is pharmacological prevention of cardiovascular risk cost-effective?

B Sigvant, M Henriksson, F Lundin… - European journal of …, 2011 - pubmed.ncbi.nlm.nih.gov
Peripheral arterial disease (PAD) is associated with an increased risk of early death in
cardiovascular (CV) disease. The majority of PAD subjects are asymptomatic with a …

Asymptomatic peripheral arterial disease: is pharmacological prevention of cardiovascular risk cost-effective?

B Sigvant, M Henriksson, F Lundin… - EUROPEAN JOURNAL …, 2011 - diva-portal.org
Peripheral arterial disease (PAD) is associated with an increased risk of early death in
cardiovascular (CV) disease. The majority of PAD subjects are asymptomatic with a …

[PDF][PDF] Asymptomatic peripheral arterial disease: is pharmacological prevention of cardiovascular risk cost-effective?

B Sigvant, M Henriksson, F Lundin, E Wahlberg - researchgate.net
Peripheral arterial disease (PAD) is associated with an increased risk of early death in
cardiovascular (CV) disease. The majority of PAD subjects are asymptomatic with a …

Asymptomatic peripheral arterial disease: is pharmacological prevention of cardiovascular risk cost-effective?

B Sigvant, M Henriksson, F Lundin… - EUROPEAN JOURNAL …, 2011 - swepub.kb.se
Peripheral arterial disease (PAD) is associated with an increased risk of early death in
cardiovascular (CV) disease. The majority of PAD subjects are asymptomatic with a …